Trial Watch

Clinical trials covered by The Clinical Lighthouse, ranked by methodological rigor and ordered by most recent.

213 trials indexed
Prehospital Whole Blood Does Not Reduce 30-Day Mortality Over Components
PIVOTAL TRIAL · LAST 30 DAYS
Randomized Controlled Trial New England Journal of Medicine

Prehospital Whole Blood Does Not Reduce 30-Day Mortality Over Components

A large-scale trial found no significant difference in 30-day mortality between prehospital whole blood and component transfusions for trauma.

May 20, 2026 Read the trial →
Chronotherapeutic Protocol Advances Circadian Timing and Extends Adolescent Sleep Randomized Controlled Trial
JAMA Pediatrics

Chronotherapeutic Protocol Advances Circadian Timing and Extends Adolescent Sleep

A two-week intervention using light-modulating glasses and scheduling increased weeknight sleep by 47 minutes in high school students.

April 21, 2026
Asundexian Reduces Recurrent Stroke Without Increasing Major Bleeding Randomized Controlled Trial
New England Journal of Medicine

Asundexian Reduces Recurrent Stroke Without Increasing Major Bleeding

Adding the Factor XIa inhibitor asundexian to standard antiplatelet therapy safely lowers recurrent stroke risk in high-risk patients.

April 21, 2026
Early EEG Findings Guide Shorter Sedation After Cardiac Arrest Non-Randomized Controlled Trial
Resuscitation

Early EEG Findings Guide Shorter Sedation After Cardiac Arrest

Patients with favorable EEG patterns within 12 hours of arrest saw mechanical ventilation and ICU stays reduced by over 50 percent.

April 21, 2026
Genicular Artery Embolization Shows No Benefit Over Sham for Knee Osteoarthritis Randomized Controlled Trial
European Radiology

Genicular Artery Embolization Shows No Benefit Over Sham for Knee Osteoarthritis

A randomized trial finds that 12-month pain reduction after genicular artery embolization is statistically equivalent to a sham procedure.

April 21, 2026
High-Intensity tACS Improves Chronic Insomnia by Modulating Brain Networks Randomized Controlled Trial
Psychotherapy and Psychosomatics

High-Intensity tACS Improves Chronic Insomnia by Modulating Brain Networks

A randomized trial shows 15 mA stimulation reduces sleep index scores and reorganizes functional connectivity in hyperarousal circuits.

April 21, 2026
Low-Calorie Feeding Does Not Worsen Kidney Function in Shock Randomized Controlled Trial
Intensive Care Medicine

Low-Calorie Feeding Does Not Worsen Kidney Function in Shock

A post hoc analysis of 3,036 patients shows early restrictive diets are safe for the kidneys, even with preexisting dysfunction.

April 21, 2026
Rapid Susceptibility Testing Speeds Antibiotic Adjustments but Not Outcomes Randomized Controlled Trial
JAMA

Rapid Susceptibility Testing Speeds Antibiotic Adjustments but Not Outcomes

While rapid testing accelerated antibiotic adjustments by 14 hours, it did not improve 30-day survival or reduce deleterious events.

April 21, 2026
Lifestyle Intervention Benefits Cognition in Older Adults With Low Hippocampal Volume Randomized Controlled Trial
JAMA Neurology

Lifestyle Intervention Benefits Cognition in Older Adults With Low Hippocampal Volume

A randomized trial shows intensive lifestyle coaching preserves cognition in high-risk patients despite unchanged brain biomarker trajectories.

April 21, 2026
Oral Celecoxib and Ciprofloxacin Slow Functional Decline in ALS Randomized Controlled Trial
JAMA Neurology

Oral Celecoxib and Ciprofloxacin Slow Functional Decline in ALS

A phase 2b trial shows the fixed-dose combination is safe and reduces the risk of severe complications over 18 months in early-stage ALS.

March 19, 2026
Apps for Alcohol Use Do Not Improve Mood Beyond Standard Care Randomized Controlled Trial
Journal of Affective Disorders

Apps for Alcohol Use Do Not Improve Mood Beyond Standard Care

In a randomized trial, digital tools added to standard care did not further reduce depression or anxiety in adults with alcohol dependence.

March 19, 2026
Structured Exercise Improves Sleep and Executive Function in Preteens With Autism Non-Randomized Controlled Trial
Frontiers in Psychiatry

Structured Exercise Improves Sleep and Executive Function in Preteens With Autism

A 10-to-12-week physical activity program objectively reduced sleep fragmentation and improved problem-solving in children with autism.

March 18, 2026
Tumor Debulking Adds Toxicity Without Survival Benefit in Metastatic Colorectal Cancer Randomized Controlled Trial
JAMA

Tumor Debulking Adds Toxicity Without Survival Benefit in Metastatic Colorectal Cancer

Adding tumor debulking to chemotherapy fails to extend survival and increases severe adverse events in metastatic colorectal cancer.

March 18, 2026
12-Week Diet and Exercise Program Improves Post-ICU Physical Function Randomized Controlled Trial
Critical Care Medicine

12-Week Diet and Exercise Program Improves Post-ICU Physical Function

A 12-week regimen of exercise and protein supplementation significantly improves physical functioning in long-stay ICU survivors.

March 18, 2026
Limiting ICU Wrist Restraints Fails to Increase Delirium-Free Days Randomized Controlled Trial
JAMA

Limiting ICU Wrist Restraints Fails to Increase Delirium-Free Days

A restrictive wrist-strap protocol in mechanically ventilated adults did not improve delirium-free days or increase self-extubation risk.

March 18, 2026
High-Flow Oxygen Lowers Intubation but Does Not Improve Survival Randomized Controlled Trial
New England journal of medicine

High-Flow Oxygen Lowers Intubation but Does Not Improve Survival

High-flow nasal cannula therapy reduces intubation rates in acute hypoxemic respiratory failure without altering 28-day mortality.

March 18, 2026
Prehospital Whole Blood Shows No Survival Benefit Over Component Therapy Randomized Controlled Trial
New England journal of medicine

Prehospital Whole Blood Shows No Survival Benefit Over Component Therapy

A randomized trial of 616 trauma patients found prehospital whole blood did not reduce 24-hour mortality or massive transfusion needs.

March 18, 2026
Web-Based School Program Reduces New-Onset Mental Health Problems Randomized Controlled Trial
Journal of Child Psychology and Psychiatry

Web-Based School Program Reduces New-Onset Mental Health Problems

An eight-session internet intervention focused on stress management lowered the one-year incidence of mental health issues from 28% to 21%.

March 17, 2026
Community Care for HIV, HTN, Diabetes Matches Clinic-Based Model Randomized Controlled Trial
The Lancet

Community Care for HIV, HTN, Diabetes Matches Clinic-Based Model

A trial in Tanzania and Uganda found non-inferior HIV suppression and comparable cardiometabolic control in a community-based model.

March 17, 2026
Women Face Worse Functional Recovery After Intensive Care EEG Randomized Controlled Trial
Critical Care Medicine

Women Face Worse Functional Recovery After Intensive Care EEG

Despite similar acute management and mortality, critically ill women are half as likely as men to achieve favorable long-term recovery.

March 17, 2026
Decision Tool Reduces Antidepressant Discontinuation in Depression Randomized Controlled Trial
JAMA

Decision Tool Reduces Antidepressant Discontinuation in Depression

A web-based system personalizing antidepressant selection kept more patients on therapy at 8 weeks and improved symptoms at 24 weeks.

March 16, 2026
Obinutuzumab Shows High Efficacy in Active Systemic Lupus Erythematosus Randomized Controlled Trial
New England Journal of Medicine

Obinutuzumab Shows High Efficacy in Active Systemic Lupus Erythematosus

A phase 3 trial shows the anti-CD20 antibody obinutuzumab significantly improves clinical responses and reduces flares in active lupus.

March 16, 2026
Pimicotinib Yields 54% Response in Tenosynovial Giant Cell Tumors Randomized Controlled Trial
The Lancet

Pimicotinib Yields 54% Response in Tenosynovial Giant Cell Tumors

The selective inhibitor pimicotinib demonstrates high efficacy for unresectable joint tumors while avoiding severe hepatotoxicity.

March 15, 2026
Zorevunersen Cuts Convulsive Seizures in Children With Dravet Syndrome Randomized Controlled Trial
New England Journal of Medicine

Zorevunersen Cuts Convulsive Seizures in Children With Dravet Syndrome

The investigational antisense therapy reduced convulsive-seizure frequency by up to 90.91% and improved adaptive behavior over 36 months.

March 15, 2026
Finerenone Reduces Albuminuria in Type 1 Diabetes and CKD Randomized Controlled Trial
New England Journal of Medicine

Finerenone Reduces Albuminuria in Type 1 Diabetes and CKD

A phase 3 trial shows the mineralocorticoid receptor antagonist finerenone safely lowers albuminuria in adults with type 1 diabetes.

March 15, 2026
Baxdrostat Reduces 24-Hour Blood Pressure in Resistant Hypertension Randomized Controlled Trial
The Lancet

Baxdrostat Reduces 24-Hour Blood Pressure in Resistant Hypertension

A phase 3 trial shows the selective aldosterone synthase inhibitor baxdrostat reduces systolic blood pressure by 14 mm Hg versus placebo.

March 15, 2026
Neoadjuvant GOLP Doubles Event-Free Survival in Cholangiocarcinoma Randomized Controlled Trial
New England Journal of Medicine

Neoadjuvant GOLP Doubles Event-Free Survival in Cholangiocarcinoma

Administering the GOLP regimen before surgery extends median event-free survival to 18 months in high-risk intrahepatic cholangiocarcinoma.

March 15, 2026
Social Skills Training Modulates Local Connectivity in the Autistic Social Brain Non-Randomized Controlled Trial
Frontiers in Psychiatry

Social Skills Training Modulates Local Connectivity in the Autistic Social Brain

A 14-week intervention reduces regional homogeneity in the medial frontal gyrus, correlating with improved social responsiveness scores.

March 15, 2026
Hybrid Dialectical Behavior Therapy Reduces Suicidal Ideation in Adolescents Randomized Controlled Trial
Frontiers in Psychiatry

Hybrid Dialectical Behavior Therapy Reduces Suicidal Ideation in Adolescents

A year-long trial shows combining online and offline DBT improves emotional regulation and depressive symptoms in self-injuring youth.

March 14, 2026
Apixaban Reduces Bleeding Risk Versus Rivaroxaban in Venous Thromboembolism Randomized Controlled Trial
New England Journal of Medicine

Apixaban Reduces Bleeding Risk Versus Rivaroxaban in Venous Thromboembolism

In a randomized trial of 2,760 patients, apixaban resulted in a 3.3% bleeding rate compared to 7.1% for rivaroxaban over three months.

March 14, 2026
Romiplostim Prevents Chemotherapy Dose Reductions in Gastrointestinal Cancers Randomized Controlled Trial
New England Journal of Medicine

Romiplostim Prevents Chemotherapy Dose Reductions in Gastrointestinal Cancers

A phase 3 trial shows romiplostim maintains platelet counts, allowing patients to receive full oxaliplatin-based chemotherapy doses.

March 14, 2026